OMND Intrinsic Valuation and Fundamental Analysis - Optimind Pharma Corp

Watchlist Manager

Watchlist

Price: 0.005 CAD Market Closed

Market Cap: CA$549k

O	Optimind Pharma Corp CNSX:OMND	CA
S	SiamEast Solutions PCL SET:SE	TH
G	G-Able PCL SET:GABLE	TH
	Cactus Inc F:43C	US
M	MFC Asset Management PCL SET:MFC	TH
T	Tong Hua Holding PCL SET:TH	TH
P	Planet Communications Asia PCL SET:PLANET	TH
A	AtomTrace as PSE:ATOMT	CZ
N	NAT Absolute Technologies PCL SET:NAT	TH
U	UBIS Asia PCL SET:UBIS	TH
C	Chubu Electric Power Co Inc F:0C2	JP
W	Window Asia PCL SET:WINDOW	TH
	MCS Services Ltd ASX:MSG	AU
T	Thaicom PCL SET:THCOM	TH
M	Maxus Mining Inc OTC:MXMGF	CA
Q	Qingco Inc OTC:QING	CN
	Naturgy Energy Group SA F:GAN	ES
N	Nestcon Bhd KLSE:NESTCON	MY
M	Micro Leasing PCL SET:MICRO	TH
I	Indigy PCL SET:IDG	TH
P	Prakit Holdings PCL SET:PRAKIT	TH

Intrinsic Value

Is OMND undervalued or overvalued?

See the intrinsic value estimate for Optimind Pharma Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

OMND Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with OMND’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price CA$0.01

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Optimind Pharma Does

Optimind Pharma Corp. provides medical cannabis. The company is headquartered in London, Ontario. The firm helps people suffering from post-traumatic stress disorder (PTSD), anxiety, depression and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. The firm also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings.

Headquarters: Canada CA
IPO date: Mar 17, 1998